Medical Equipment

Insulin Delivery Devices Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Insulin Delivery Devices Market Between 2026 And 2030?

The insulin delivery devices market has demonstrated significant expansion in recent years. Its value is expected to rise from $19.07 billion in 2025 to $20.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. Over the past period, this growth has been fueled by the increasing prevalence of diabetes, enhanced awareness concerning diabetes management, improved access to insulin therapies, the broadening of healthcare services, and the growing adoption of self-injection techniques.

The insulin delivery devices market is poised for significant expansion over the upcoming years. Its valuation is projected to reach $28.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period stems from factors such as an expanding global diabetic population, a heightened need for user-friendly insulin delivery approaches, an increased emphasis on managing diabetes over the long term, broader availability of diabetes care in developing economies, and the greater uptake of home healthcare solutions. Key trends identified for the forecast timeframe involve a surge in the use of insulin pens compared to conventional syringes, an escalating requirement for insulin pumps to facilitate continuous insulin administration, a stronger inclination towards insulin devices that are easy to use and portable, an increase in home-centered diabetes management options, and an expanding utilization of disposable and pre-filled insulin delivery systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Drivers Are Influencing The Insulin Delivery Devices Market?

The rising occurrence of diabetes is anticipated to drive the expansion of the insulin delivery devices market in the future. This chronic ailment, diabetes, is characterized by elevated blood sugar concentrations, stemming from either insufficient insulin synthesis by the pancreas or the body’s incapacity to properly use insulin. The incidence of diabetes is escalating mainly as a result of elements like inactive lifestyles, poor dietary habits, and an uptick in global obesity levels. For individuals with diabetes, insulin delivery devices are essential tools that facilitate the effective regulation of blood sugar levels through controlled and convenient insulin administration, thus averting complications and fostering well-being. As an illustration, data from the International Diabetes Federation, a Belgium-based non-governmental organization, indicates that in 2024, roughly 589 million adults aged 20–79 globally are afflicted with diabetes. This figure is predicted to climb to 853 million by 2050. Consequently, the increasing spread of diabetes is fueling the expansion of the insulin delivery devices market.

Which Market Segments Are Examined In The Insulin Delivery Devices Market Study?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

Which Trends Are Influencing The Insulin Delivery Devices Market?

Leading companies within the insulin delivery devices market are developing innovative products, such as insulin pumps, to offer continuous or customizable insulin administration. Insulin pumps are programmable medical instruments that deliver insulin consistently or on demand through a catheter inserted beneath the skin. For example, in May 2023, Beta Bionics, a US-based medical technology firm, announced U.S. Food and Drug Administration approval for both the iLet ACE Pump and the iLet Dosing Decision Software. The iLet Bionic Pancreas system is engineered for individuals aged six and older with type 1 diabetes, integrating two components with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). It operates via an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which initially only uses the user’s body weight for setup and removes the requirement for additional insulin dosing parameters. Unlike traditional pump therapy, this system necessitates no manual adjustment of settings, thereby simplifying its initiation and management. The iLet device also includes a meal announcement feature that streamlines mealtime insulin dosing by classifying meals as small, medium, or large, with the algorithm learning and adapting to individual insulin needs over time.

Who Are The Primary Competitors In The Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

Read the full insulin delivery devices market report here:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Insulin Delivery Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2026, By The Business Research Company

Wearable Ai Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-ai-global-market-report

Smart Wearables Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-wearables-global-market-report

Wearable Computing Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-computing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795